ALPAT Stock Overview
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Plant Advanced Technologies SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €10.00 |
| 52 Week High | €14.00 |
| 52 Week Low | €2.90 |
| Beta | 1.02 |
| 1 Month Change | 104.92% |
| 3 Month Change | 78.57% |
| 1 Year Change | -24.24% |
| 3 Year Change | -54.75% |
| 5 Year Change | -40.83% |
| Change since IPO | -24.24% |
Recent News & Updates
Shareholder Returns
| ALPAT | FR Biotechs | FR Market | |
|---|---|---|---|
| 7D | -4.8% | -3.9% | -0.03% |
| 1Y | -24.2% | -11.7% | 1.8% |
Return vs Industry: ALPAT underperformed the French Biotechs industry which returned -12.1% over the past year.
Return vs Market: ALPAT underperformed the French Market which returned 1.7% over the past year.
Price Volatility
| ALPAT volatility | |
|---|---|
| ALPAT Average Weekly Movement | 15.1% |
| Biotechs Industry Average Movement | 6.8% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALPAT's share price has been volatile over the past 3 months.
Volatility Over Time: ALPAT's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 56 | Jean-Paul Fevre | www.plantadvanced.com |
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include PAT Plant Milking that produces active extracts through plant stimulation and living-root exudation while preserving plants; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. The company was incorporated in 2005 and is headquartered in Vandœuvre-lès-Nancy, France.
Plant Advanced Technologies SA Fundamentals Summary
| ALPAT fundamental statistics | |
|---|---|
| Market cap | €10.87m |
| Earnings (TTM) | -€849.00k |
| Revenue (TTM) | €2.34m |
4.6x
P/S Ratio-12.8x
P/E RatioIs ALPAT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALPAT income statement (TTM) | |
|---|---|
| Revenue | €2.34m |
| Cost of Revenue | €2.39m |
| Gross Profit | -€48.00k |
| Other Expenses | €801.00k |
| Earnings | -€849.00k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.78 |
| Gross Margin | -2.05% |
| Net Profit Margin | -36.30% |
| Debt/Equity Ratio | 86.1% |
How did ALPAT perform over the long term?
See historical performance and comparison